VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
KVUEKenvue Inc.
$18.12$34.8B
Research
OverviewAnalysis
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

KVUE logoKenvue Inc.(KVUE)Earnings, Financials & Key Ratios

KVUE•NYSE
23.8× P/E·Price updated Jun 19, 2026
SectorConsumer DefensiveIndustryHousehold ProductsSub-IndustryConsumer Health and Wellness Products
AboutKenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.Show more
  • Revenue$15.12B-2.1%
  • EBITDA$3.26B+32.4%
  • Net Income$1.47B+42.7%
  • EPS (Diluted)0.76+40.7%
  • Gross Margin58.13%+0.3%
  • EBITDA Margin21.56%+35.3%
  • Operating Margin17.88%+50.1%
  • Net Margin9.72%+45.8%
  • ROE14.39%+45.8%

KVUE Key Insights

Kenvue Inc. (KVUE) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Dividend Aristocrat: 56 years of consecutive increases
  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Healthy dividend yield of 4.5%
  • ✓Healthy 5Y average net margin of 11.0%

✗Weaknesses

  • ✗Dividend payout exceeds 100% of earnings

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when KVUE posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

KVUE Price & Volume

Kenvue Inc. (KVUE) stock price & volume — 10-year historical chart

Loading chart...

KVUE Growth Metrics

Kenvue Inc. (KVUE) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years0.89%
3 Years0.39%
TTM-0.07%

Profit CAGR

10 Years-
5 Years-
3 Years-10.7%
TTM53.6%

EPS CAGR

10 Years-
5 Years-
3 Years-11.05%
TTM54.49%

Return on Capital

10 Years8.75%
5 Years11.4%
3 Years10.96%
Last Year13.19%

KVUE Recent Earnings

Kenvue Inc. (KVUE) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
May 7, 2026
Metric
Actual
Est
EPS
$0.32+22.1%
$0.26
Rev
$3.9B+1.7%
$3.8B
Q1 2026
Feb 17, 2026
Metric
Actual
Est
EPS
$0.27+21.2%
$0.22
Rev
$3.8B+2.6%
$3.7B
Q4 2025
Nov 3, 2025
Metric
Actual
Est
EPS
$0.28+7.6%
$0.26
Rev
$3.8B-1.5%
$3.8B
Q3 2025
Aug 7, 2025
Metric
Actual
Est
EPS
$0.29+2.9%
$0.28
Rev
$3.8B-0.4%
$3.9B
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 7, 2026
$0.32vs $0.26+22.1%
$3.9Bvs $3.8B+1.7%
Q1 2026Feb 17, 2026
$0.27vs $0.22+21.2%
$3.8Bvs $3.7B+2.6%
Q4 2025Nov 3, 2025
$0.28vs $0.26+7.6%
$3.8Bvs $3.8B-1.5%
Q3 2025Aug 7, 2025
$0.29vs $0.28+2.9%
$3.8Bvs $3.9B-0.4%
Based on last 12 quarters of dataView full earnings history →

KVUE Peer Comparison

Kenvue Inc. (KVUE) competitors in Consumer Health and Wellness Products — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
PG logoPGThe Procter & Gamble CompanyDirect Competitor351.4B150.3823.100.29%14.66%23.78%0.68
CL logoCLColgate-Palmolive CompanyDirect Competitor71.79B89.4834.021.4%10.46%251.59%21.88
CHD logoCHDChurch & Dwight Co., Inc.Direct Competitor22.65B95.6431.671.57%11.81%17.45%0.55
EL logoELThe Estée Lauder Companies Inc.Direct Competitor30.62B84.81-26.92-8.46%-1.67%-6.29%2.44
PRGO logoPRGOPerrigo Company plcProduct Competitor1.42B10.25-1.00-2.75%-43.5%-50.65%1.35
HLN logoHLNHaleon plcProduct Competitor39.9B8.9618.73-3.96%14.46%19.9%0.52
COTY logoCOTYCoty Inc.Product Competitor1.72B1.95-4.43-3.68%-9.26%-14.13%1.07
JNJ logoJNJJohnson & JohnsonSupply Chain550.4B228.3939.454.3%27.26%31.69%0.51

Compare KVUE vs Peers

Kenvue Inc. (KVUE) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs PG

Most directly comparable listed peer for KVUE.

Scale Benchmark

vs AMZN

Larger-name benchmark to compare KVUE against a more recognizable public peer.

Peer Set

Compare Top 5

vs PG, CL, CHD, EL

KVUE Income Statement

Kenvue Inc. (KVUE) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
14.47B15.05B14.95B15.44B15.46B15.12B15.29B
Revenue Growth %
-4.06%-0.69%3.3%0.07%-2.14%-0.07%
Cost of Goods Sold
6.62B6.63B6.67B6.8B6.5B6.33B6.37B
COGS % of Revenue
45.75%44.07%44.58%44.04%42.03%41.87%-
Gross Profit
7.85B▲ 0%
8.42B▲ 7.3%
8.29B▼ 1.6%
8.64B▲ 4.3%
8.96B▲ 3.7%
8.79B▼ 1.9%
8.93B▲ 0%
Gross Margin %
54.25%55.93%55.42%55.96%57.97%58.13%58.37%
Gross Profit Growth %
-7.28%-1.59%4.32%3.66%-1.86%-
Operating Expenses
8.83B5.5B5.61B6.13B7.12B6.09B5.93B
OpEx % of Revenue
61.01%36.53%37.53%39.7%46.06%40.25%-
Selling, General & Admin
4.96B5.48B5.63B6.14B6.03B6.09B6B
SG&A % of Revenue
34.26%36.43%37.68%39.76%39%40.25%-
Research & Development
00000382M84M
R&D % of Revenue
-----2.53%-
Other Operating Expenses
3.87B15M-23M-10M1.09B-382M0
Operating Income
-979M▲ 0%
2.92B▲ 398.3%
2.67B▼ 8.4%
2.51B▼ 6.1%
1.84B▼ 26.7%
2.7B▲ 46.9%
3B▲ 0%
Operating Margin %
-6.77%19.4%17.89%16.27%11.91%17.88%19.62%
Operating Income Growth %
-398.26%-8.39%-6.09%-26.71%46.88%-
EBITDA
-233M3.65B3.32B3.14B2.46B3.26B3.56B
EBITDA Margin %
-1.61%24.25%22.2%20.32%15.94%21.56%23.31%
EBITDA Growth %
-1666.95%-9.09%-5.42%-21.54%32.4%45.04%
D&A (Non-Cash Add-back)
746M731M644M627M622M557M564M
EBIT
2.99B2.92B2.64B2.55B1.85B2.38B2.69B
Net Interest Income
000-250M-378M-379M-380M
Interest Income
000108M53M013M
Interest Expense
000358M431M379M393M
Other Income/Expense
-37M5M-38M-322M-426M-705M-788M
Pretax Income
-1.02B▲ 0%
2.92B▲ 387.9%
2.64B▼ 9.8%
2.19B▼ 17.0%
1.42B▼ 35.4%
2B▲ 41.3%
2.21B▲ 0%
Pretax Margin %
-7.02%19.43%17.64%14.18%9.16%13.22%14.47%
Income Tax
-137M847M573M526M385M529M591M
Effective Tax Rate %
13.48%28.96%21.73%24.02%27.21%26.46%26.71%
Net Income
-879M▲ 0%
2.08B▲ 336.4%
2.06B▼ 0.7%
1.66B▼ 19.4%
1.03B▼ 38.1%
1.47B▲ 42.7%
1.62B▲ 0%
Net Margin %
-6.08%13.8%13.81%10.77%6.66%9.72%10.61%
Net Income Growth %
-336.41%-0.67%-19.38%-38.1%42.72%53.6%
Net Income (Continuing)
-879M2.08B2.06B1.66B1.03B1.47B1.62B
Discontinued Operations
0000000
Minority Interest
0000000
EPS (Diluted)
-0.47▲ 0%
1.10▲ 334.0%
1.08▼ 1.8%
0.87▼ 19.4%
0.54▼ 37.9%
0.76▲ 40.7%
0.84▲ 0%
EPS Growth %
-334.04%-1.82%-19.44%-37.93%40.74%54.49%
EPS (Basic)
-0.471.101.080.900.540.77-
Diluted Shares Outstanding
1.89B1.89B1.91B1.92B1.92B1.92B1.92B
Basic Shares Outstanding
1.89B1.89B1.91B1.85B1.92B1.92B1.92B
Dividend Payout Ratio
---874.64%150.68%107.55%-

KVUE Balance Sheet

Kenvue Inc. (KVUE) balance sheet — assets, liabilities & shareholders' equity

MetricDec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
4.59B4.93B5.88B6.14B5.53B5.7B5.79B
Cash & Short-Term Investments
618M740M1.23B1.38B1.07B1.06B1.07B
Cash Only
618M740M1.23B1.38B1.07B1.06B1.07B
Short-Term Investments
0000000
Accounts Receivable
2.13B2.33B2.3B2.64B2.66B00
Days Sales Outstanding
53.7456.5256.0862.3962.8-31.46
Inventory
1.69B1.7B2.23B1.85B1.59B1.67B1.67B
Days Inventory Outstanding
92.9293.63121.999.3489.496.0399.05
Other Current Assets
162M154M123M265M205M2.97B3.05B
Total Non-Current Assets
24.58B23B21.44B21.71B20.08B21.38B21.06B
Property, Plant & Equipment
1.96B1.83B1.82B2.04B1.85B2.21B2.21B
Fixed Asset Turnover
7.39x8.24x8.21x7.56x8.36x6.84x7.15x
Goodwill
10.33B9.81B9.19B9.27B8.84B9.51B9.38B
Intangible Assets
11.61B10.7B9.85B9.62B8.47B8.69B8.54B
Long-Term Investments
0000001M
Other Non-Current Assets
496M475M434M623M726M727M703M
Total Assets
29.18B▲ 0%
27.93B▼ 4.3%
27.32B▼ 2.2%
27.85B▲ 2.0%
25.6B▼ 8.1%
27.08B▲ 5.8%
26.85B▲ 0%
Asset Turnover
0.50x0.54x0.55x0.55x0.60x0.56x0.56x
Asset Growth %
--4.28%-2.19%1.96%-8.08%5.76%11.84%
Total Current Liabilities
7.49B4.04B3.93B5.48B5.74B5.95B5.9B
Accounts Payable
1.58B1.83B1.83B2.49B2.25B2.47B2.53B
Days Payables Outstanding
87.07100.51100.16133.58126.65142.55143.01
Short-Term Debt
000599M1.55B1.45B1.59B
Deferred Revenue (Current)
0000000
Other Current Liabilities
252M266M272M406M325M2.02B1.77B
Current Ratio
0.61x1.22x1.50x1.12x0.96x0.96x0.98x
Quick Ratio
0.39x0.80x0.93x0.78x0.69x0.68x0.70x
Cash Conversion Cycle
59.5849.6477.8228.1525.54--12.5
Total Non-Current Liabilities
3.33B3.49B3.42B11.16B10.19B10.37B10.35B
Long-Term Debt
008.93B7.69B6.94B7.07B7.07B
Capital Lease Obligations
082M81M97M189M0194M
Deferred Tax Liabilities
1.76B2.43B2.48B2.62B2.26B2.35B9.51B
Other Non-Current Liabilities
1.57B976M-8.07B754M802M941M924M
Total Liabilities
10.82B7.53B7.35B16.64B15.93B16.31B16.25B
Total Debt
0129M9.05B8.43B8.72B8.52B8.66B
Net Debt
-618M-611M7.82B7.04B7.65B7.46B7.59B
Debt / Equity
-0.01x0.45x0.75x0.90x0.79x0.82x
Debt / EBITDA
-0.04x2.73x2.68x3.54x2.61x2.43x
Net Debt / EBITDA
--0.17x2.35x2.24x3.11x2.29x2.13x
Interest Coverage
---7.12x4.28x6.27x6.85x
Total Equity
18.36B▲ 0%
20.4B▲ 11.1%
19.97B▼ 2.1%
11.21B▼ 43.9%
9.67B▼ 13.8%
10.77B▲ 11.3%
10.61B▲ 0%
Equity Growth %
-11.13%-2.1%-43.86%-13.76%11.35%22.2%
Book Value per Share
9.7210.8010.435.855.035.605.52
Total Shareholders' Equity
18.36B20.4B19.97B11.21B9.67B10.77B10.61B
Common Stock
00019M19M19M19M
Retained Earnings
000429M-93M-204M-128M
Treasury Stock
000-7M-242M00
Accumulated OCI
-3.57B-4.47B-5.46B-5.38B-6.15B-4.96B-5.21B
Minority Interest
0000000

KVUE Cash Flow Statement

Kenvue Inc. (KVUE) cash flow — operating, investing & free cash flow history

MetricDec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
3.4B334M2.52B3.17B1.77B2.2B2.26B
Operating CF Margin %
23.48%2.22%16.89%20.51%11.45%14.53%-
Operating CF Growth %
--90.17%655.99%25.47%-44.16%24.19%81.15%
Net Income
-879M2.03B2.09B1.66B1.03B1.47B1.62B
Depreciation & Amortization
746M731M644M627M622M557M564M
Stock-Based Compensation
115M141M137M188M254M136M92M
Deferred Taxes
-801M568M157M-114M-285M-108M-67M
Other Non-Cash Items
-26M-5M13M6M719M90M173M
Working Capital Changes
4.24B-3.13B-513M797M-571M52M-126M
Change in Receivables
265M-303M-142M44M-218M-112M-37M
Change in Inventory
109M-77M-582M349M182M-12M47M
Change in Payables
154M330M52M390M-536M41M-63M
Cash from Investing
-83M-171M-390M-488M-425M-436M-436M
Capital Expenditures
-229M-295M-375M-469M-434M-500K39.5M
CapEx % of Revenue
1.58%1.96%2.51%3.04%2.81%0%0.26%
Acquisitions
176M136M-10M21M000
Investments
-------
Other Investing
146M-77M-8M-40M9M-435.5M-475.5M
Cash from Financing
-3.46B0-1.58B-2.53B-1.56B-1.84B-1.82B
Debt Issued (Net)
-11M-7M14M8.25B159M-150M2M
Equity Issued (Net)
0004.24B-235M-197M63M
Dividends Paid
000-14.55B-1.55B-1.58B-6M
Share Repurchases
0000-235M-197M63M
Other Financing
-3.45B7M-1.6B-460M63M91M-1.88B
Net Change in Cash
-134M▲ 0%
122M▲ 191.0%
491M▲ 302.5%
151M▼ 69.2%
-312M▼ 306.6%
-8M▲ 97.4%
18M▲ 0%
Free Cash Flow
3.17B▲ 0%
39M▼ 98.8%
2.15B▲ 5412.8%
2.7B▲ 25.5%
1.33B▼ 50.5%
1.72B▲ 29.0%
1.82B▲ 0%
FCF Margin %
21.9%0.26%14.38%17.48%8.64%11.39%11.92%
FCF Growth %
--98.77%5412.82%25.53%-50.54%28.99%25.72%
FCF per Share
1.680.021.121.410.690.900.95
FCF Conversion (FCF/Net Income)
-3.86x0.16x1.22x1.90x1.72x1.49x1.12x
Interest Paid
000224M439M00
Taxes Paid
448M363M316M699M810M00

KVUE Key Ratios

Kenvue Inc. (KVUE) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric20212022202320242025TTM
Return on Equity (ROE)
10.72%10.23%10.67%9.87%14.39%15.18%
Return on Invested Capital (ROIC)
11.67%8.43%8.18%7.76%11.41%12.26%
Gross Margin
55.93%55.42%55.96%57.97%58.13%58.37%
Net Margin
13.8%13.81%10.77%6.66%9.72%10.61%
Debt / Equity
0.01x0.45x0.75x0.90x0.79x0.82x
Interest Coverage
--7.12x4.28x6.27x6.85x
FCF Conversion
0.16x1.22x1.90x1.72x1.49x1.12x
Revenue Growth
4.06%-0.69%3.3%0.07%-2.14%-0.07%
Related:KVUE Dividend History·KVUE Revenue History·KVUE Price History·KVUE P/E History·KVUE Financial Ratios·KVUE Institutional Holders

KVUE SEC Filings & Documents

Kenvue Inc. (KVUE) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 7, 2026·SEC

Material company update

Apr 15, 2026·SEC

Material company update

Feb 17, 2026·SEC

10-K Annual Reports

1
FY 2026

Feb 20, 2026·SEC

10-Q Quarterly Reports

4
FY 2026

May 7, 2026·SEC

FY 2025

Nov 3, 2025·SEC

FY 2025

Aug 7, 2025·SEC

KVUE Frequently Asked Questions

Kenvue Inc. (KVUE) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Kenvue Inc. (KVUE) reported $15.29B in revenue for fiscal year 2025. This represents a 6% increase from $14.47B in 2020.

Kenvue Inc. (KVUE) saw revenue decline by 2.1% over the past year.

Yes, Kenvue Inc. (KVUE) is profitable, generating $1.62B in net income for fiscal year 2025 (9.7% net margin).

Dividend & Returns

Yes, Kenvue Inc. (KVUE) pays a dividend with a yield of 4.53%. This makes it attractive for income-focused investors.

Kenvue Inc. (KVUE) has a return on equity (ROE) of 14.4%. This is reasonable for most industries.

Kenvue Inc. (KVUE) generated $1.82B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in KVUE back in 2020?

Total return calculator · dividends reinvested · 6+ years of data

See returns →

How much would $100/month in KVUE be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →